{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T05:06:07Z","timestamp":1780031167270,"version":"3.53.1"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) represent a spectrum of acute respiratory failure arising from the same underlying pathophysiological processes and are associated with substantial morbidity and mortality worldwide. Although corticosteroids such as Dexamethasone are commonly administered to patients with moderate-to-severe ARDS, their clinical benefit remains controversial, and systemic administration is often associated with significant adverse effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We developed a targeting ligand-free, sulfonium lipid nanoparticle (sLNP)-based drug delivery system, Dex\/DOSEH, for intravenous lung-targeted delivery of dexamethasone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In a lipopolysaccharide (LPS)-induced murine ALI model, treatment with Dex\/DOSEH formulation significantly reduced proinflammatory cytokine production, decreased immune cell infiltration, preserved capillary-alveolar barrier integrity, and attenuated histopathological lung injury compared with controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Our findings demonstrate that Dex\/DOSEH drug formulation enables effective lung-targeted delivery of dexamethasone and achieves robust anti-inflammatory therapeutic efficacy in ALI. This platform represents a promising therapeutic strategy for the treatment of ALI\/ARDS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1821659","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:52:00Z","timestamp":1780030320000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Lung-specific sulfonium lipid nanoparticle formulation of dexamethasone suppresses endotoxin-induced lung inflammation"],"prefix":"10.3389","volume":"17","author":[{"given":"Yuqin","family":"Men","sequence":"first","affiliation":[{"name":"Department of Pharmacology, State University of New York, Upstate Medical University","place":["Syracuse, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Surgery, State University of New York, Upstate Medical University","place":["Syracuse, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David O.","family":"Popoola","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, State University of New York, Upstate Medical University","place":["Syracuse, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, State University of New York, Upstate Medical University","place":["Syracuse, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weikun","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Surgery, State University of New York, Upstate Medical University","place":["Syracuse, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Cooney","sequence":"additional","affiliation":[{"name":"Department of Surgery, State University of New York, Upstate Medical University","place":["Syracuse, NY, United States"]},{"name":"Sepsis Interdisciplinary Research Center (SIRC), State University of New York, Upstate Medical University","place":["Syracuse, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghe","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Surgery, State University of New York, Upstate Medical University","place":["Syracuse, NY, United States"]},{"name":"Sepsis Interdisciplinary Research Center (SIRC), State University of New York, Upstate Medical University","place":["Syracuse, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, State University of New York, Upstate Medical University","place":["Syracuse, NY, United States"]},{"name":"Sepsis Interdisciplinary Research Center (SIRC), State University of New York, Upstate Medical University","place":["Syracuse, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41379-021-00915-6","article-title":"Acute lung injury-from cannabis to COVID","volume":"35","author":"Beasley","year":"2022","journal-title":"Mod Pathol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2015-0519-RA","article-title":"Acute lung injury: a clinical and molecular review","volume":"140","author":"Butt","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","volume":"315","author":"Bellani","year":"2016","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2011.05.005","article-title":"Epidemiology of ARDS and ALI","volume":"27","author":"Blank","year":"2011","journal-title":"Crit Care Clin"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01485-4","article-title":"Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes","volume":"400","author":"Bos","year":"2022","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.33549\/physiolres.934602","article-title":"Acute lung injury - from pathophysiology to treatment","volume":"69","author":"Mokra","year":"2020","journal-title":"Physiol Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2007.01060.x","article-title":"Do glucocorticoids decrease mortality in acute respiratory distress syndrome? A meta-analysis","volume":"12","author":"Agarwal","year":"2007","journal-title":"Respirology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12931-022-02186-4","article-title":"Safety and efficacy of corticosteroids in ARDS patients: a systematic review and meta-analysis of RCT data","volume":"23","author":"Chang","year":"2022","journal-title":"Respir Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000001071","article-title":"Adverse effects related to corticosteroid use in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia: a systematic review and meta-analysis","volume":"6","author":"Chaudhuri","year":"2024","journal-title":"Crit Care Explor"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13496","article-title":"Glucocorticoids for acute respiratory distress syndrome: a systematic review with meta-analysis and trial sequential analysis","volume":"51","author":"Junhai","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2009.08.009","article-title":"Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: a meta-analysis of randomized controlled trials","volume":"25","author":"Lamontagne","year":"2010","journal-title":"J Crit Care"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial","volume":"8","author":"Villar","year":"2020","journal-title":"Lancet Respir Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1039\/c9tb02538c","article-title":"Improving the anti-inflammatory efficacy of dexamethasone in the treatment of rheumatoid arthritis with polymerized stealth liposomes as a delivery vehicle","volume":"8","author":"Wang","year":"2020","journal-title":"J Mater Chem B"},{"key":"B15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1208\/s12249-019-1449-1","article-title":"A lipid micellar system loaded with dexamethasone palmitate alleviates rheumatoid arthritis","volume":"20","author":"Wang","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1039\/d3tb02316h","article-title":"Tea polyphenol carrier-enhanced dexamethasone nanomedicines for inflammation-targeted treatment of rheumatoid arthritis","volume":"11","author":"Yi","year":"2023","journal-title":"J Mater Chem B"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2020.100071","article-title":"Engineering osteogenic microenvironments by combination of multilayers from collagen type I and chondroitin sulfate with novel cationic liposomes","volume":"7","author":"Brito Barrera","year":"2020","journal-title":"Mater Today Bio"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1636-16.2016","article-title":"Anti-inflammatory modulation of microglia via CD163-targeted glucocorticoids protects dopaminergic neurons in the 6-OHDA Parkinson's disease model","volume":"36","author":"Tentillier","year":"2016","journal-title":"J Neurosci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2010.01.013","article-title":"Solid lipid nanoparticles as anti-inflammatory drug delivery system in a human inflammatory bowel disease whole-blood model","volume":"39","author":"Serpe","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1039\/d1bm00924a","article-title":"Targeted delivery of dexamethasone in acute pneumonia","volume":"9","author":"Ma","year":"2021","journal-title":"Biomater Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1039\/c7nr04480a","article-title":"Enhanced topical delivery of dexamethasone by beta-cyclodextrin decorated thermoresponsive nanogels","volume":"10","author":"Giulbudagian","year":"2017","journal-title":"Nanoscale"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13091347","article-title":"Lung targeted lipopolymeric microspheres of dexamethasone for the treatment of ARDS","volume":"13","author":"Kotta","year":"2021","journal-title":"Pharmaceutics"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1039\/d5na00419e","article-title":"Dexamethasone-loaded lipid-polymeric nanoparticles to improve therapy for cisplatin-induced sensorineural hearing loss","volume":"8","author":"Qi","year":"2025","journal-title":"Nanoscale Adv"},{"key":"B24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11051-025-06363-6","article-title":"Innovative polymeric and non-polymeric nanocarrier systems for dexamethasone: enhancing precision and reducing side effects","volume":"27","author":"Pourmadadi","year":"2025","journal-title":"J Nanopart Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12951-018-0431-5","article-title":"Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy","volume":"16","author":"Li","year":"2018","journal-title":"J Nanobiotechnology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16070878","article-title":"Solid lipid nanoparticles loaded with dexamethasone palmitate for pulmonary inflammation treatment by nebulization approach","volume":"16","author":"Chen","year":"2024","journal-title":"Pharmaceutics"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2025.08.032","article-title":"Sulfonium lipid nanoparticles for intranasal mRNA delivery to lung epithelial and immune cells","volume":"205","author":"Men","year":"2025","journal-title":"Acta Biomater"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.4c01854","article-title":"Lung-specific mRNA delivery enabled by sulfonium lipid nanoparticles","volume":"24","author":"Popoola","year":"2024","journal-title":"Nano Lett"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1039\/d5bm00590f","article-title":"Lung-targeting lipid nanoparticle-mediated sparstolonin B delivery improves acute lung injury","volume":"13","author":"Meng","year":"2025","journal-title":"Biomater Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2009-0210ST","article-title":"An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals","volume":"44","author":"Matute-Bello","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for RNA delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Acc Chem Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"7233","DOI":"10.1038\/s41467-021-27493-0","article-title":"An ionizable lipid toolbox for RNA delivery","volume":"12","author":"Han","year":"2021","journal-title":"Nat Commun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2022.04.013","article-title":"Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.37356","article-title":"Rational design of anti-inflammatory lipid nanoparticles for mRNA delivery","volume":"110","author":"Zhang","year":"2022","journal-title":"J BioMed Mater Res A"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.64898\/2026.01.22.701009","article-title":"Lung-targeting interleukin-10 mRNA lipid nanoparticles ameliorate acute lung injury","author":"Men","year":"2026","journal-title":"bioRxiv"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6362344","article-title":"Classic signaling pathways in alveolar injury and repair involved in sepsis-induced ALI\/ARDS: new research progress and prospect","volume":"2022","author":"Li","year":"2022","journal-title":"Dis Markers"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2S","DOI":"10.1378\/chest.116.suppl_1.2s","article-title":"Lung cytokines and ARDS: roger S. Mitchell lecture","volume":"116","author":"Martin","year":"1999","journal-title":"Chest"},{"key":"B40","doi-asserted-by":"publisher","first-page":"20241076","DOI":"10.1515\/med-2024-1076","article-title":"Progress in cytokine research for ARDS: a comprehensive review","volume":"19","author":"Zhou","year":"2024","journal-title":"Open Med (Wars)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13613-025-01513-4","article-title":"Crosstalk between lung and extrapulmonary organs in sepsis-related acute lung injury\/acute respiratory distress syndrome","volume":"15","author":"Li","year":"2025","journal-title":"Ann Intensive Care"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1097\/MCC.0b013e32834ef3ea","article-title":"Organ crosstalk during acute lung injury, acute respiratory distress syndrome, and mechanical ventilation","volume":"18","author":"Quilez","year":"2012","journal-title":"Curr Opin Crit Care"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000002118","article-title":"Prophylactic n CMT-3 attenuates sepsis-induced acute kidney injury in association with NLRP3 inflammasome activation and apoptosis","volume":"59","author":"Ma","year":"2023","journal-title":"Shock"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001927","article-title":"Nano-chemically modified tetracycline-3 (nCMT-3) attenuates acute lung injury via blocking sTREM-1 release and NLRP3 inflammasome activation","volume":"57","author":"Meng","year":"2022","journal-title":"Shock"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1532391","article-title":"Sparstolonin B nano-formulation attenuates LPS-induced lung injury","volume":"16","author":"Meng","year":"2025","journal-title":"Front Pharmacol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040897","article-title":"The role of macrophages in the development of acute and chronic inflammatory lung diseases","volume":"10","author":"Lee","year":"2021","journal-title":"Cells"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1615748","article-title":"Decoding immune-metabolic crosstalk in ARDS: a transcriptomic exploration of biomarkers, cellular dynamics, and therapeutic pathways","volume":"16","author":"Wu","year":"2025","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2100109","DOI":"10.1002\/anbr.202100109","article-title":"Lipid nanoparticles for drug delivery","volume":"2","author":"Xu","year":"2021","journal-title":"Advanced NanoBioMed Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12101148","article-title":"Recent advances in lipid nanoparticles and their safety concerns for mRNA delivery","volume":"12","author":"Wang","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.001677","article-title":"Development of animal models for the acute respiratory distress syndrome","volume":"2","author":"Bastarache","year":"2009","journal-title":"Dis Model Mech"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1821659\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:52:05Z","timestamp":1780030325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1821659\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2026.1821659"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1821659","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"article-number":"1821659"}}